> Details

Arbon, Dominik; Ženíšková, Kateřina; Šubrtová, Karolína; Mach, Jan; Štursa, Jan; Machado, Marta; Zahedifard, Farnaz; Leštinová, Tereza; Hierro-Yap, Carolina; Neuzil, Jiri; Volf, Petr; Ganter, Markus; Zoltner, Martin; Zíková, Alena; Werner, Lukáš; Sutak, Robert

Repurposing of MitoTam: Novel Anti-Cancer Drug Candidate Exhibits Potent Activity against Major Protozoan and Fungal Pathogens

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Repurposing of MitoTam: Novel Anti-Cancer Drug Candidate Exhibits Potent Activity against Major Protozoan and Fungal Pathogens
  • Contributor: Arbon, Dominik; Ženíšková, Kateřina; Šubrtová, Karolína; Mach, Jan; Štursa, Jan; Machado, Marta; Zahedifard, Farnaz; Leštinová, Tereza; Hierro-Yap, Carolina; Neuzil, Jiri; Volf, Petr; Ganter, Markus; Zoltner, Martin; Zíková, Alena; Werner, Lukáš; Sutak, Robert
  • Published: American Society for Microbiology, 2022
  • Published in: Antimicrobial Agents and Chemotherapy, 66 (2022) 8
  • Language: English
  • DOI: 10.1128/aac.00727-22
  • ISSN: 0066-4804; 1098-6596
  • Origination:
  • Footnote:
  • Description: Many of the currently available anti-parasitic and anti-fungal frontline drugs have severe limitations, including adverse side effects, complex administration, and increasing occurrence of resistance. The discovery and development of new therapeutic agents is a costly and lengthy process.
  • Access State: Open Access